The United States is reportedly going to pay $ 1.6 billion to the Novavax company to develop a new type of corona virus (covid-19) vaccine. The pharmaceutical company, Novavax, operating in the state of Maryland, USA, announced that the US government will pay them $ 1.6 billion at the beginning of next year, in exchange for producing 100 million doses of Kovid-19 vaccines.
It is noted that the agreement was made under the project called “Warp Speed”, which was created in order to fulfill the promise of US President Donald Trump to find a coronavirus vaccine by the end of the year.
Novavax company stated that the budget covers all test steps and production process. According to the agreement with the US government, the company stated that they can start vaccine production without waiting for the results of expected clinical trials until the end of the year, and if the coronavirus vaccine is confirmed to be safe and effective, it has committed to reaching 100 million dose stocks for 50 million people in the first quarter of 2021.
Novavax manager Stanley Erck also announced that first-phase tests will begin next week, and third-phase manned experiments will focus in October.
“The addition of Novavax’s Warp Speed” operation to the vaccine diversification portfolio increases our chances of having a safe and effective vaccine as soon as possible at the end of this year, “US Health Minister Alex M. Azar said in a written statement on the subject. he gave.
It is known that Novavax promised to produce 10 million doses of vaccines to the Ministry of Defense in June to protect American troops against coronavirus, and in turn signed a $ 60 million contract.
British pharmaceutical company AstraZeneca, which said that the vaccine it developed could be ready in October as part of the War Speed project, was also granted $ 1.2 billion in federal aid.
Apart from that, 4 more companies named Johnson and Johnson, Sanofi, Moderna Therapeutics and Merck are among the companies that received federal aid for vaccination from the American government.